# Durolane Versus Methylprednisolone in Knee Osteoarthritis

> **NCT01209364** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 442 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** Durolane is a device, methylprednisolone in a drug

## Key facts

- **NCT ID:** NCT01209364
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-01
- **Final completion:** 2008-11
- **Target enrollment:** 442 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209364, "Durolane Versus Methylprednisolone in Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01209364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*